background
explor
cellular
immun
cytokin
statu
ncp
patient
predict
correl
cellular
immun
level
cytokin
sever
patient
method
ncp
patient
divid
mild
sever
group
peripher
blood
collect
lymphocyt
subset
cytokin
detect
correl
analysi
perform
lymphocyt
subset
cytokin
differ
index
two
group
analyz
result
mild
sever
patient
includ
lymphocyt
subset
reduc
two
group
proport
reduct
mild
sever
group
respect
proport
b
cell
reduct
proport
nk
cell
reduct
detect
valu
mild
group
mild
group
significantli
lower
proport
patient
higher
normal
sever
group
signific
linear
correl
lymphocyt
subset
cytokin
signific
differ
notic
two
group
conclus
low
level
common
sever
ncp
level
higher
sever
patient
cell
subset
cytokin
use
one
basi
predict
transit
mild
sever
larg
number
sampl
still
need
confirm
warn
valu
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
diagnos
accord
world
health
organ
interim
guidanc
ncp
divid
mild
sever
includ
sever
critic
group
blood
sampl
patient
collect
nurs
accord
doctor
order
patient
treat
blood
sampl
receiv
standard
treatment
accord
diagnosi
treatment
scheme
ncp
two
test
tube
taken
patient
number
b
respect
antibodi
beij
tongshengshidai
biotechnolog
co
ltd
ad
tube
antibodi
ad
tube
b
ad
edta
anticoagul
whole
blood
tube
tube
vortex
kept
room
temperatur
minut
dark
sampl
detect
fourcolor
fluoresc
label
flow
cytometri
mindray
bricyt
mindray
shenzhen
china
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
detect
reagent
cytokin
provid
qingdao
raisecar
biotechnolog
co
ltd
calibr
lot
number
six
cytokin
includ
tnf
ifn
detect
multipl
microspher
flow
immunofluoresc
accord
manufactur
instruct
blood
sampl
correspond
flow
tube
number
anticoagul
whole
blood
centrifug
r
min
min
experiment
buffer
centrifug
plasma
captur
microspher
antibodi
detect
antibodi
ad
correspond
flow
tube
incub
room
temperatur
hour
dark
gentl
shake
sape
ad
flow
tube
respect
incub
continu
minut
subsequ
dilut
wash
buffer
ad
flow
tube
second
vortex
shake
flow
tube
centrifug
min
minut
liquid
slowli
pour
flow
tube
invert
absorb
paper
dilut
wash
buffer
ad
flow
tube
accord
requir
flow
cytomet
test
perform
shake
second
statist
analys
perform
use
spss
spss
inc
chicago
il
usa
descript
analys
perform
categor
variabl
gender
continu
variabl
inspect
result
express
compar
use
independ
sampl
test
correl
analysi
result
express
pearson
correl
coeffici
larger
r
indic
better
linear
correl
p
consid
statist
signific
studi
approv
ethic
committe
chongq
three
gorg
central
hospit
inform
consent
obtain
patient
studi
popul
includ
hospit
patient
confirm
ncp
ncp
patient
male
femal
mean
age
year
mild
group
ncp
patient
male
femal
mean
age
year
sever
group
enrol
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
accord
result
index
b
cell
nk
cell
divid
normal
valu
within
normal
valu
normal
valu
correspond
quantiti
proport
respect
calcul
result
shown
tabl
sever
patient
lower
normal
patient
within
normal
patient
lower
normal
patient
within
normal
patient
b
cell
lower
normal
patient
within
normal
patient
nk
cell
lower
normal
patient
within
normal
patient
patient
ratio
within
normal
valu
patient
lower
normal
valu
higher
normal
valu
tnf
ifn
divid
valu
within
normal
valu
normal
valu
normal
valu
accord
result
variou
indic
correspond
quantiti
proport
count
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
patient
patient
higher
normal
valu
consid
valu
chang
mild
sever
group
correl
lymphocyt
subset
cytokin
analyz
data
valu
group
case
light
group
case
sever
group
exclud
case
mild
group
case
sever
group
includ
correl
analysi
shown
tabl
correl
analysi
lymphocyt
subset
show
pearson
correl
coeffici
b
cell
nk
cell
low
signific
linear
correl
sever
ncp
data
case
case
ifn
mild
group
index
valu
two
group
exclud
two
independentsampl
test
perform
lymphocyt
subset
cytokin
mild
group
sever
group
inspect
level
signific
differ
observ
mild
group
sever
group
p
signific
differ
detect
b
cell
nk
cell
tnf
ifn
two
group
p
tabl
lymphocyt
subset
play
import
role
bodi
cellular
immun
regul
cell
restrict
regul
studi
found
among
ncp
patient
reduct
rate
account
mild
group
sever
group
reduct
rate
account
mild
group
sever
group
indic
lymphocyt
inhibit
sever
patient
bodi
resist
infect
consist
research
conclus
huabiao
chen
sar
coronaviru
reveal
bodi
respond
way
cope
homolog
coronaviru
infect
reduct
ratio
b
cell
mild
group
sever
group
respect
signific
differ
reduct
ratio
nk
cell
account
mild
group
sever
group
suggest
infect
limit
activ
nk
cell
certain
extent
view
fact
immun
adjuv
improv
activ
nk
cell
research
result
may
provid
new
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
result
studi
suggest
signific
linear
correl
lymphocyt
subset
cytokin
analyz
differ
lymphocyt
subset
cytokin
peripher
blood
mild
sever
patient
found
statist
signific
mild
sever
group
suggest
immunosuppress
sever
patient
infect
obviou
consist
opinion
mani
expert
sever
result
studi
exampl
proport
patient
valu
mild
group
high
signific
differ
term
tnf
ifn
two
group
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
initi
specif
immun
respons
reason
yet
confirm
studi
sever
limit
firstli
largest
diagnosi
treatment
center
patient
ncp
chongq
area
hospit
patient
far
sampl
size
rel
small
compar
wuhan
diseas
origin
may
impact
statist
result
whole
number
patient
area
middl
level
part
countri
except
wuhan
research
result
rel
reliabl
secondli
humor
immun
level
includ
patient
monitor
certain
defici
evalu
immun
system
thirdli
due
largescal
outbreak
epidem
restrict
flow
peopl
data
healthi
patient
lack
blank
futur
studi
data
collect
healthi
patient
blank
control
explor
predict
valu
peripher
blood
lymphocyt
subset
cytokin
patient
infect
time
cooper
design
treatment
unit
carri
multicent
research
includ
confirm
infect
patient
expand
sampl
size
design
rigor
random
control
trial
addit
strengthen
followup
patient
cure
discharg
regularli
detect
patient
peripher
blood
lymphocyt
subset
cytokin
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
